Regulon

Regulon: R-1570

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
15-0.70143510Pr-136Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9183 ENSG00000086827 ZW10 O43264
988 ENSG00000096401 CDC5L Q99459
28960 ENSG00000110063 DCPS Q96C86
2976 ENSG00000115207 GTF3C2 Q8WUA4
25926 ENSG00000130935 NOL11 Q9H8H0
4076 ENSG00000135387 CAPRIN1 Q14444
96764 ENSG00000137574 TGS1 Q96RS0
10152 ENSG00000138443 ABI2 F8WEB9
4236 ENSG00000140259 MFAP1 P55081
51542 ENSG00000143952 VPS54 Q9P1Q0
54465 ENSG00000143971 ETAA1 Q9NY74
6240 ENSG00000167325 RRM1 P23921
3308 ENSG00000170606 HSPA4 P34932
10978 ENSG00000172409 CLP1 Q92989
9943 ENSG00000172939 OXSR1 O95747

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
CLOFARABINEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
GALLIUM NITRATERRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
GEMCITABINE HYDROCHLORIDERRM1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
HYDROXYUREARRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor43
GEMCITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
TEZACITABINERRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor20
TRIAPINERRM1Small moleculeINHIBITORRibonucleotide reductase inhibitor30
FLUDARABINE PHOSPHATEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor41
MOTEXAFIN GADOLINIUMRRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor31

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1570

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs